Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Donehower

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Seminars in Oncology|June 1, 1992
An overview of the clinical experience with hydroxyureaR C Donehower
Stem Cells (Dayton, Ohio)|January 1, 1996
The clinical development of paclitaxel: a successful collaboration of academia, industry and the National Cancer InstituteR C Donehower
Journal of the National Cancer Institute|December 19, 1990
Evaluating cancer chemotherapy by infusionR C Donehower
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Metabolic conversion of methotrexate in manR C Donehower
Oncology (Williston Park, N.Y.)|February 24, 2001
Role of oral chemotherapy in colorectal cancerR C Donehower
Journal of the National Cancer Institute|October 19, 1988
Understanding trimetrexate toxicityR C Donehower
Cancer Treatment Reports|November 1, 1984
Hepatic toxicity of low doses of mithramycin in hypercalcemiaL Green, R C Donehower
Pharmacology & Therapeutics|October 1, 1991
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeuticsE K Rowinsky, R C Donehower
Current Opinion in Oncology|November 1, 1993
Therapeutic modalitiesR C Donehower, J M Kirkwood
Cancer Treatment and Research|January 1, 1995
Recent clinical advances with camptothecin analoguesW J Slichenmyer, R C Donehower
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Seminars in Oncology|June 1, 1992
An overview of the clinical experience with hydroxyureaR C Donehower
Stem Cells (Dayton, Ohio)|January 1, 1996
The clinical development of paclitaxel: a successful collaboration of academia, industry and the National Cancer InstituteR C Donehower
Journal of the National Cancer Institute|December 19, 1990
Evaluating cancer chemotherapy by infusionR C Donehower
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Metabolic conversion of methotrexate in manR C Donehower
Oncology (Williston Park, N.Y.)|February 24, 2001
Role of oral chemotherapy in colorectal cancerR C Donehower
Journal of the National Cancer Institute|October 19, 1988
Understanding trimetrexate toxicityR C Donehower
Cancer Treatment Reports|November 1, 1984
Hepatic toxicity of low doses of mithramycin in hypercalcemiaL Green, R C Donehower
Pharmacology & Therapeutics|October 1, 1991
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeuticsE K Rowinsky, R C Donehower
Current Opinion in Oncology|November 1, 1993
Therapeutic modalitiesR C Donehower, J M Kirkwood
Cancer Treatment and Research|January 1, 1995
Recent clinical advances with camptothecin analoguesW J Slichenmyer, R C Donehower
Pageof 13